| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0001758> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0010174> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0010181> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0010187> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0012622> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0030685> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0032752> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0032753> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0041703> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0080071> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0086067> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0150099> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C0282620> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C1511536> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C3853022> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C3853051> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C3853052> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C3899107> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33650025_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Evidence for Access, Genentech, Inc, South San Francisco, CA, USA.\', \'Health Economics, BresMed Health Solutions, Las Vegas, NV, USA.\', \'Evidence for Access, Genentech, Inc, South San Francisco, CA, USA. kowal.stacey@gene.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Dang_Joseph> <https://research.tib.eu/covid-19/entity/Elsea_David> <https://research.tib.eu/covid-19/entity/Kowal_Stacey> <https://research.tib.eu/covid-19/entity/Meng_Yang> <https://research.tib.eu/covid-19/entity/Shah_Anuj> <https://research.tib.eu/covid-19/entity/Sheinson_Daniel>
?:doi	10.1007/s12325-021-01654-5
?:doi	<https://research.tib.eu/covid-19/entity/10.1007/s12325-021-01654-5>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Advances in therapy
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33650025>
?:pmid	<https://research.tib.eu/covid-19/entity/33650025>
?:pmid	33650025
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.075
?:rankingScore_hIndex	51
?:title	A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33650025>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33650025>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all